AcelRx Pharmaceuticals Inc. (ACRX): Ready for an explosive trading day – Invest Chronicle

AcelRx Pharmaceuticals Inc. (ACRX): Ready for an explosive trading day

At the end of the latest market close, AcelRx Pharmaceuticals Inc. (ACRX) was valued at $0.57. In that particular session, Stock kicked-off at the price of $0.57 while reaching the peak value of $0.58 and lowest value recorded on the day was $0.53. The stock current value is $0.54.Recently in News on January 12, 2022, AcelRx Pharmaceuticals Announces Publication of an Editorial by an Internationally Recognized Leader in Opioid-Sparing Surgery Highlighting the Potential Advantages of the Sufentanil Sublingual Tablet in Joint Replacement Surgery. AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the publication of an editorial regarding the use of sufentanil sublingual tablet (SST; DSUVIA®) in total joint replacement surgery by Dr. Scott Sigman in the Journal of Orthopaedic Experience and Innovation. Dr. Sigman is a board-certified orthopedic surgeon at Orthopedic Surgical Associates of Lowell, the former Chief of Orthopedics at Lowell General Hospital in Lowell Massachusetts, and an internationally recognized leader in opioid-sparing orthopedic surgery. You can read further details here

AcelRx Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.6499 on 01/04/22, with the lowest value was $0.5100 for the same time period, recorded on 01/06/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


AcelRx Pharmaceuticals Inc. (ACRX) full year performance was -73.07%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, AcelRx Pharmaceuticals Inc. shares are logging -81.77% during the 52-week period from high price, and 16.52% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.46 and $2.94.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 883137 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the AcelRx Pharmaceuticals Inc. (ACRX) recorded performance in the market was -4.32%, having the revenues showcasing -47.45% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 74.45M, as it employees total of 25 workers.

Analysts verdict on AcelRx Pharmaceuticals Inc. (ACRX)

During the last month, 0 analysts gave the AcelRx Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 0.8268, with a change in the price was noted -0.51. In a similar fashion, AcelRx Pharmaceuticals Inc. posted a movement of -48.95% for the period of last 100 days, recording 997,680 in trading volumes.

>> 7 Top Picks for the Post-Pandemic Economy << 

AcelRx Pharmaceuticals Inc. (ACRX): Technical Analysis

Raw Stochastic average of AcelRx Pharmaceuticals Inc. in the period of last 50 days is set at 16.89%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 40.02%. In the last 20 days, the company’s Stochastic %K was 46.88% and its Stochastic %D was recorded 43.12%.

Let’s take a glance in the erstwhile performances of AcelRx Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -4.32%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -60.59%, alongside a downfall of -73.07% for the period of the last 12 months. The shares increased approximately by -4.29% in the 7-day charts and went down by 2.92% in the period of the last 30 days. Common stock shares were lifted by -47.45% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts